While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.

Australia is home to some truly unique and unexpected creatures, but few are quite as strange and fascinating as the platypus ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...